Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care

ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-99
SponsorNational Cancer Centre, Singapore

About this trial

There is evidence for the effectiveness and feasibility of the individual components of TIER-HF-PC, however there is a need to test how these individual components interact to allow the researchers to deliver TIER-HF-PC as a model of care in its totality. In the short term, this study will assess if TIER-HF-PC is beneficial for patients and caregivers.

Eligibility criteria

Qualifiers

21 years or older and

able to communicate in English or Chinese and

be of stage C or D heart failure, as defined by American College of Cardiology/American Heart Association (ACC/AHA) classification system and

have functional limitation of New York Heart Association (NYHA) functional status of at least 2 or more and

Disqualifiers

have cognitive impairment (e.g., dementia)

have severe, untreated, active mental illness (e.g., major depressive disorder)

have ventricular assist device implant.

have non-reversible hearing or visual loss or

Trial design

Treatments tested in this trial

  • TIER-HF-PC
  • Usual Care

Treatment groups

240 Participants
are divided into 2 treatment groups

Sponsors and collaborators

National Cancer Centre, Singapore

Lead sponsor

National Heart Centre Singapore

Collaborator

Khoo Teck Puat Hospital

Collaborator